Draft:Michelle Volovsky

Michelle Volovsky (born in 1994) is a medical doctor specializing in Obstetrics and Gynecology, with a particular focus on reproductive medicine. Currently serving as an In Vitro Fertilization. (IVF) fellow at Yale School of Medicine, Volovsky is known for her research contributions in assisted reproductive technology (ART), pelvic pain management, and endometrial biology

Education & Training
Michelle Volovsky received her medical education and training from prestigious institutions:


 * Education
 * Monash University, Faculty of Medicine - Australia
 * Internship
 * The Royal Melbourne Hospital
 * Residency
 * Maimonides Medical Center

Career and Research
Dr. Michelle Volovsky is affiliated with Yale Medicine as an IVF fellow, working in the Department of Obstetrics and Gynecology. She has made significant contributions to the field of reproductive medicine through her research endeavors.

Notable Publications

 * 1) "The Effects of Adjuvant Therapies on Embryo Transfer Success"
 * 2) * This study, published in the Journal of Reproduction & Infertility in October 2017, analyzed the impact of various adjuvant therapies on embryo transfer success. Authors Michelle Volovsky, R. Shirlow, M. Healey, V. Maclachlan, and B. Vollenhoven observed negative effects with the use of melatonin, while aspirin or steroids demonstrated promising, potentially beneficial outcomes.
 * 3) "Should intrauterine human chorionic gonadotropin infusions ever be used prior to embryo transfer?"
 * 4) * Published in the Journal of Assisted Reproduction and Genetics in February 2018, this study by Michelle Volovsky, M. Healey, V. Maclachlan, and B. Vollenhoven examined the use of intrauterine hCG infusions prior to embryo transfer. The findings suggested a negative effect in fresh embryo transfers and those without recurrent implantation failure.
 * 5) "Comparing pregnancy outcomes between natural cycles and artificial cycles following frozen‐thaw embryo transfers"
 * 6) * Michelle Volovsky and colleagues investigated pregnancy outcomes in natural cycles versus artificial cycles following frozen-thaw embryo transfers. This study, published in the Australian and New Zealand Journal of Obstetrics and Gynaecology in July 2020, highlighted the increasing adoption of artificial cycle preparation over natural cycles to facilitate greater access to frozen embryo transfer.
 * 7) "Progesterone concentrations and dosage with frozen embryo transfers – What's best?"
 * 8) * Published in the Australian and New Zealand Journal of Obstetrics and Gynaecology in October 2018, this study by S. Basnayake, Michelle Volovsky, L. Rombauts, T. Osianlis, B. Vollenhoven, and M. Healey addressed the lack of consensus on the optimal dose and form of progesterone supplementation during frozen-thawed embryo transfer with hormone replacement therapy.

Other Contributions
In addition to her research publications, Michelle Volovsky has contributed to various studies examining topics such as fibroids, progesterone supplementation in frozen embryo transfer cycles, and the effects of adjuvant therapies on embryo transfer success.

Personal Life
Michelle Volovsky resides in New Haven, Connecticut.